Inhibition of Staphylococcus aureus PriA Helicase by Flavonol Kaempferol

Yen-Hua Huang1, Chien-Chih Huang, Cheng-Chieh Chen

  • 1School of Biomedical Sciences, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd., Taichung City, Taiwan.

The Protein Journal
|April 21, 2015
PubMed

Insights

Flavonols kaempferol and myricetin inhibit Staphylococcus aureus PriA (SaPriA), an essential enzyme for bacterial survival. This discovery offers potential new strategies for combating healthcare-associated infections caused by S. aureus.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Staphylococcus aureus is a significant cause of healthcare-associated infections.
  • Bacterial helicases, like S. aureus PriA (SaPriA), are crucial for DNA replication restart and bacterial survival.
  • Identifying novel inhibitors of essential bacterial enzymes is vital for developing new antimicrobial strategies.

Purpose of the Study:

  • To investigate the inhibitory effects of flavonoids on Staphylococcus aureus PriA (SaPriA).
  • To explore the potential of natural products as therapeutic agents against S. aureus.

Main Methods:

  • Vanadate-sensitive colorimetric assay to measure ATP hydrolysis by SaPriA.
  • Enzyme inhibition assays to determine IC50 values.
  • Fluorescence quenching to assess the binding kinetics of flavonoids to SaPriA.

Main Results:

  • Kaempferol and myricetin significantly inhibited SaPriA activity at 35 μM, reducing phosphate concentration by 37% and 69%, respectively.
  • The IC50 of kaempferol for SaPriA was determined to be 22 ± 2 μM.
  • Kaempferol demonstrated binding to SaPriA with a K(d) of 9.1 ± 3.2 μM.

Conclusions:

  • Flavonols, specifically kaempferol and myricetin, are potent inhibitors of Staphylococcus aureus PriA.
  • These findings represent the first report of natural products targeting the SaPriA helicase.
  • This study highlights the potential of kaempferol and myricetin as leads for developing novel anti-staphylococcal agents.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
57
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
141
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
919
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.3K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
99
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
68